Literature DB >> 26617882

Curcumin prevents the non-alcoholic fatty hepatitis via mitochondria protection and apoptosis reduction.

Long Wang1, Yisong Lv2, Huixiang Yao1, Li Yin1, Jianhui Shang2.   

Abstract

BACKGROUND: Non-alcoholic fatty hepatitis (NASH) is highly prevalent, mitochondria damage is the main pathophysiological characteristic of NASH. However, treatment for mitochondria damage is rarely reported.
METHODS: NASH model was established in rats, the protective effects of curcumin were evaluated by histological observation; structure and function assessments of mitochondria; and apoptotic genes expression.
RESULTS: NASH rats treated with curcumin displayed relatively slight liver damage when compared with NASH livers. The average mitochondrial length and width of NASH (12.0 ± 3.2 and 5.1 ± 1.1 micrometers) were significantly longer than that of normal (6.2 ± 2.1 and 2.1 ± 1.5 micrometers) and NASH treated with curcumin (7.4 ± 1.2 and 3.2 ± 1.5 micrometers) rats. The average malondialdehyde (MDA) and 4-hydroxy nonyl alcohol (HNE) levels in liver homogenates of NASH rats (4.23 ± 0.22 and 19.23 ± 2.3 nmol/Ml) were significantly higher than these in normal (1.32 ± 0.12 and 3.52 ± 0.43 nmol/mL) and NASH treated with curcumin (1.74 ± 0.11 and 4.66 ± 0.99 nmol/mL) rats. The expression levels of CytC, Casp3 and Casp8 of the NASH livers were significantly higher than normal and NASH treated with curcumin rats livers.
CONCLUSION: Our data demonstrated that curcumin prevents the NASH by mitochondria protection and apoptosis reduction and provided a possible novel treatment for NASH.

Entities:  

Keywords:  Curcumin; apoptosis; mitochondria damage; non-alcoholic fatty hepatitis

Mesh:

Substances:

Year:  2015        PMID: 26617882      PMCID: PMC4637698     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  24 in total

1.  Correlated three-dimensional light and electron microscopy reveals transformation of mitochondria during apoptosis.

Authors:  Mei G Sun; James Williams; Cristina Munoz-Pinedo; Guy A Perkins; Joshua M Brown; Mark H Ellisman; Douglas R Green; Terrence G Frey
Journal:  Nat Cell Biol       Date:  2007-08-26       Impact factor: 28.824

2.  Analyzing real-time PCR data by the comparative C(T) method.

Authors:  Thomas D Schmittgen; Kenneth J Livak
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

3.  Non-alcoholic fatty liver disease in an area of southern Italy: main clinical, histological, and pathophysiological aspects.

Authors:  C Loguercio; V De Girolamo; I de Sio; C Tuccillo; A Ascione; F Baldi; G Budillon; L Cimino; A Di Carlo; M P Di Marino; F Morisco; F Picciotto; L Terracciano; R Vecchione; V Verde; C Del Vecchio Blanco
Journal:  J Hepatol       Date:  2001-11       Impact factor: 25.083

Review 4.  Mitochondria in steatohepatitis.

Authors:  D Pessayre; A Berson; B Fromenty; A Mansouri
Journal:  Semin Liver Dis       Date:  2001       Impact factor: 6.115

5.  Liver injury attenuation by curcumin in a rat NASH model: an Nrf2 activation-mediated effect?

Authors:  B Li; L Wang; Q Lu; W Da
Journal:  Ir J Med Sci       Date:  2014-11-11       Impact factor: 1.568

6.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

Authors:  E M Brunt; C G Janney; A M Di Bisceglie; B A Neuschwander-Tetri; B R Bacon
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

Review 7.  Curcumin: the Indian solid gold.

Authors:  Bharat B Aggarwal; Chitra Sundaram; Nikita Malani; Haruyo Ichikawa
Journal:  Adv Exp Med Biol       Date:  2007       Impact factor: 2.622

8.  Hepatoprotective Effect of Curcumin on Lindane-induced Oxidative Stress in Male Wistar Rats.

Authors:  Rambir Singh; Poonam Sharma
Journal:  Toxicol Int       Date:  2011-07

9.  Intracellular ROS protection efficiency and free radical-scavenging activity of curcumin.

Authors:  Abolfazl Barzegar; Ali A Moosavi-Movahedi
Journal:  PLoS One       Date:  2011-10-10       Impact factor: 3.240

10.  Mitochondria-ros crosstalk in the control of cell death and aging.

Authors:  Saverio Marchi; Carlotta Giorgi; Jan M Suski; Chiara Agnoletto; Angela Bononi; Massimo Bonora; Elena De Marchi; Sonia Missiroli; Simone Patergnani; Federica Poletti; Alessandro Rimessi; Jerzy Duszynski; Mariusz R Wieckowski; Paolo Pinton
Journal:  J Signal Transduct       Date:  2011-11-14
View more
  8 in total

1.  Protective Effects of Quercetin on Mitochondrial Biogenesis in Experimental Traumatic Brain Injury via the Nrf2 Signaling Pathway.

Authors:  Xiang Li; Handong Wang; Yongyue Gao; Liwen Li; Chao Tang; Guodao Wen; Yuan Zhou; Mengliang Zhou; Lei Mao; Youwu Fan
Journal:  PLoS One       Date:  2016-10-25       Impact factor: 3.240

Review 2.  The Pharmacological Targets and Clinical Evidence of Natural Products With Anti-hepatic Inflammatory Properties.

Authors:  Jinghua Peng
Journal:  Front Pharmacol       Date:  2018-06-05       Impact factor: 5.810

Review 3.  Curcumin and Health.

Authors:  Mario Pulido-Moran; Jorge Moreno-Fernandez; Cesar Ramirez-Tortosa; Mcarmen Ramirez-Tortosa
Journal:  Molecules       Date:  2016-02-25       Impact factor: 4.411

4.  Dihydroartemisinin Inhibits Proliferation and Induces Apoptosis of Human Hepatocellular Carcinoma Cell by Upregulating Tumor Necrosis Factor via JNK/NF-κB Pathways.

Authors:  Long Wu; Yanlei Cheng; Junjian Deng; Weiping Tao; Junjie Ye
Journal:  Evid Based Complement Alternat Med       Date:  2019-08-25       Impact factor: 2.629

5.  Effects of curcumin on oxidative stress, inflammation and apoptosis in L-arginine induced acute pancreatitis in mice.

Authors:  Prasong Siriviriyakul; Thidarat Chingchit; Naruemon Klaikeaw; Maneerat Chayanupatkul; Duangporn Werawatganon
Journal:  Heliyon       Date:  2019-08-27

6.  Novel Combinatorial Regimen of Garcinol and Curcuminoids for Non-alcoholic Steatohepatitis (NASH) in Mice.

Authors:  Muhammed Majeed; Shaheen Majeed; Kalyanam Nagabhushanam; Lincy Lawrence; Lakshmi Mundkur
Journal:  Sci Rep       Date:  2020-05-04       Impact factor: 4.379

7.  Tanshinone IIA Ameliorates Nonalcoholic Steatohepatitis in Mice by Modulating Neutrophil Extracellular Traps and Hepatocyte Apoptosis.

Authors:  Lianjie Xu; Xiao Liu; Tao Jia; Yanhong Sun; Yan Du; Shanshan Wei; Wei Wang; Yurong Zhang; Wenhui Chen; Shan Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-01       Impact factor: 2.650

Review 8.  Regulation of Mitochondrial Function by Natural Products for the Treatment of Metabolic Associated Fatty Liver Disease.

Authors:  Tingting Shi; Liping Yu; Rangxiao Zhuang; Jianjun Xi; Ruoyu He; Yidan Shao; Jinsong Huang; Shourong Liu; Xingxin Yang
Journal:  Can J Gastroenterol Hepatol       Date:  2021-06-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.